P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 494-498

  Goodman, Cammi ^a   Jeyendran, R S ^b   Coulam, C B ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Andrology Laboratory Services   (United States)

^c CARI Testing Institute LLC   (United States)

Author keywords

gene polymorphisms; P53 tumor suppressor factor; plasminogen activator inhibitor; recurrent pregnancy loss; vascular endothelial growth factor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN P53; VASCULOTROPIN;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DETERMINATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NIDATION; PREVALENCE; PRIORITY JOURNAL;

ADULT; FEMALE; FERTILIZATION IN VITRO; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ILLINOIS; INCIDENCE; INFERTILITY, FEMALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; TREATMENT FAILURE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67651083497     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.022     Document Type: Article

References (40)

1. Center for Disease Control. 2002 assisted reproductive technology (ART) report: introduction to the 2002 national report. 2005. Available at: http://www.cdc.gov/ART/ART02/nation.htm. Accessed 20 November 2007.
2. Smith S.K. Angiogenesis and implantation. Hum Reprod 15 (2000) 59-66
3. Simon C., Dominguez F., Remohi J., and Pellicer A. Embryo effects in human implantation: embryonic regulation of endometrial molecules in human implantation. Ann N Y Acad Sci 943 (2001) 1-6
4. Nardo L.G., Nikas G., and Makrigiannakis A. Molecules in blastocyst implantation. Role of matrix metalloproteinases, cytokines and growth factors. J Reprod Med 48 (2003) 137-147
5. Aflalo E.D., Sod-Moriah U.A., Potashnik G., and Har-Vardi I. Differences in the implantation rates of rat embryos developed in vivo and in vitro: possible role for plasminogen activators. Fertil Steril Suppl 1 (2004) 780-785
6. Savion S., Lepsky E., Orenstein H., Carp H., Shepshelovich J., Torchinsky A., et al. Apoptosis in the uterus of mice with pregnancy loss. Am J Reprod Immunol 47 (2002) 118-127
7. Dameron K.M., Volpert O.V., Tainsky M.A., and Bouck N. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor Symp Quant Biol 59 (1994) 483-489
8. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
9. Kay C., Jeyendran R.S., and Coulam C.B. P53 tumour suppressor polymorphism is associated with recurrent implantation failure. Reprod Biomed Online 13 (2006) 492-496
10. Coulam C.B., Jeyendran R.S., Fishel L.A., and Roussev R.G. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online 12 (2006) 322-327
11. Goodman C., Jeyendran R.S., and Coulam C.B. Vascular endothelial growth factor gene polymorphisms and recurrent implantation failure. Reprod Biomed Online 16 (2008) 720-727
12. Coulam C.B. Implantation failure and immunotherapy. Hum Reprod 10 (1995) 1338-1340
13. Kaider A.S., Kaider B.D., Janowicz P.B., and Roussev R.G. Immunodiagnositic evaluation in women with reproductive failure. Am J Reprod Immunol 42 (1999) 335-346
14. Pietrowski D., Bettendorf H., Riener E.K., Keck C., Hefler L.A., Huber J.C., et al. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Hum Reprod 20 (2005) 848-851
15. Sartori M.T., Wiman B., Vettore S., Dazzi F., Girolami A., and Patrassi G.M. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 80 (1998) 956-960
16. Coulam C.B., and Jeyendran R.S. Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am J Reprod Immunol 59 (2008) 301-305
17. Brogan I.J., Khan N., Isauc K., Hutchinson J.A., Pruvica V., and Hutchinson I.V. Novel polymorphisms in the promoter and 5′UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60 (1999) 1245-1249
18. Dimitriadis E., White C.A., Jones R.L., and Salamonsen L.A. Cytokines and growth factors in endometrium related to implantation. Hum Reprod Update 11 (2005) 613-630
19. Galen A., Herrer R., Remohi J., Pellicer A., and Simon C. Embryonic regulation of endometrial epithelial apoptosis during human implantation. Hum Reprod 15 (2000) 74-80
20. Pim D., and Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Internat J Cancer 108 (2004) 196-199
21. Pijnenborg R., Robertson W.B., Brosens I., and Dixon G. Review article: trophoblast invasion and the establishment of haemchorial placenta ion in man and laboratory animals. Placenta 2 (1981) 71-91
22. Enders A.C., and Lopata A. Implantation in the marmoset monkey: expansion of the early implantation site. Anat Rec 256 (1999) 279-299
23. Chung H.W., Wen Y., Ahn J.J., Moon H.S., and Polan M.L. Interleukin-1 beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stomal cells. J Clin Endocrinol Metab 86 (2001) 1332-1340
24. Festa A., D'Agostino R., Rich S.S., Jenny N.S., Tracy R.P., and Haffner S.M. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plansminogen activator-1 levels in blacks, Hispanics and non Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 20 (2003) 2422-2427
25. Tayade C., Black G.P., Fang Y., and Croy B.A. Differential gene expression in endometrium, endometrial lymphocytes and trophoblasts during successful and abortive embryo implantation. J Immunol 176 (2006) 148-156
26. Kapiteijn K., Koolwijk P., van der Weiden R.M.F., van Nieuw Amerongen G., Plaisier M., van Hinsberg V.W.M., et al. Human embryo-conditioned medium stimulates in vitro endometrial angiogenesis. Fertil Steril 85 (2006) 1232-1239
27. Ravi M., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., Dillehay L.E., et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha. Genes Develop 14 (2000) 34-44
28. Yuan A., Yu C.J., Luh K.T., Kuo S.H., Lee Y.C., and Yang P.C. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in nonsmall-cell lung cancer. J Clin Oncol 20 (2002) 900-910
29. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
30. Ferrara N., Curver-Moore K., Chen H., Dowd M., Lu L., O'Shea K., et al. Heterozygous embryonic lethality by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
31. Mohammadi M., Ollier W.E., and Hutchinsdon I.V. A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells. Hum Immunol 64 (2003) S125
32. Zhou Y., Mc Master M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
33. Rabbani M.L., and Rogers P.A. Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. Reproduction 122 (2001) 85-90
34. Rowe A.J., Wulff C., and Fraser H.M. Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the peri-implantaion period and early pregnancy in marmosets (Callithrix jacchus). Reproduction 126 (2003) 227-238
35. Te Velde E.A., Exalto N., Hesseling P., and van der Linden H.C. First trimester development of human chorionic villous vascularization studied with CD34 immunohistochemistry. Hum Reprod 12 (1997) 1577-1581
36. Zygmuni M., Herr P., Munstedt K., Lang U., and Liung O.D. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 110 (2003) S10-S18
37. Kruessel J.S., Behr B., Milki A.A., Hirchenhain J., Wen Y., Bielfeld P., et al. Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts. Mol Hum Reprod 7 (2001) 57-63
38. Munne S., Lee A., Rosenwak Z., Grifo J., and Cohen J. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 8 (1993) 2185-2191
39. Madon P.F., Athakye A.S., and Parikh P. Polymorphic variants on chromosomes probably play a significant role in infertility. Reprod Biomed Online 11 (2005) 726-732
40. Urman B., Yakin K., and Balaban B. Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple. Reprod Biomed Online 11 (2005) 371-381